To find out more about HSRPP 2022, see the main conference webpage.

Monday 11 April Tuesday 12 April
9:30 GMT+1 Networking and posters 9:30 GMT+1 Networking and posters
10:00 GMT+1 Welcome and keynote speaker 10:00 GMT+1 Welcome and keynote speaker
11:00 GMT+1 Break, networking and posters 11:00 GMT+1 Break, networking and posters
11:30 GMT+1 Oral papers (parallel sessions 1 to 3) 11:30 GMT+1 Oral papers (parallel sessions 4 to 6)
12:30 GMT+1 Lunch 12:30 GMT+1 Lunch
13:00 GMT+1 Keynote speakers 13:00 GMT+1 Oral papers (parallel sessions 7 to 9)
13:45 GMT+1 Workshops (parallel sessions) 14:00 GMT+1 Prize-giving, conference summary, HSRPP 2023
14:45 GMT+1 End of day 1 14:30 GMT+1 End of day 2

Abstracts

Abstracts for all our oral papers and digital posters are available in this supplement of the International Journal of Pharmacy Practice. No subscription is required.

Oral papers parallel sessions

Oral papers 1: Patient perspectives and co-design

“They were waiting for me and welcomed me with great love and escorted me to my room” – a qualitative approach exploring patients’ experiences of the cancer healthcare services

Alison Brincat, School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, Scotland.

Exploring elderly patients’ perspectives on deprescribing: a qualitative study interim analysis

Kiran Channa, Pharmacy, University Hospitals Coventry and Warwickshire, Coventry, England.

Supporting sAFE and GradUAl ReDuctIon of loNG-term BenzodiaZepine Receptor Agonist uSe: Development of the SAFEGUARDING-BZRAs toolkit using a co-design approach

Tom Lynch, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Oral papers 2: Deprescribing and medication review

A feasibility study of a pharmacist led proton pump inhibitor deprescribing intervention in older patients in an Irish hospital

Margaret Horgan, Pharmacy Department, Mercy University Hospital, Cork, Ireland.

Using risk prediction to case-find frail older people at risk of anticholinergic burden for Structured Medication Reviews: a qualitative study exploring the views and perspectives of primary care professionals

David Mehdizadeh, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.

Routinely implementing safe deprescribing in primary care: a scoping review

Daniel Okeowo, School of Healthcare, University of Leeds, Leeds, UK.

Oral papers 3: Antimicrobial stewardship

Antimicrobial consumption in hospitalised COVID-19 patients: a systematic review and meta-analysis

Sidra Khan, Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.

Fijian farmers' attitude and knowledge towards antimicrobial use and antimicrobial resistance in livestock production systems: a qualitative study

Xavier Khan, Department of Animal Sciences, University of Reading, Reading, UK.

Exploring determinants of antimicrobial prescribing behaviour: a qualitative study using the Theoretical Domains Framework

Hend Talkhan, School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK.

Oral papers 4: Community pharmacy

Determining the cause and frequency of prescription reworks in community pharmacies

Kieran Dalton, Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland.

A national initiative to promote public involvement in medicine safety in Scotland: the use of a population survey to identify candidate behaviours for intervention development

Jaheeda Gangannagaripalli, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland.

Making community pharmacies psychologically informed environments: a pilot study to improve delivery of care for people with a drug problem

Catriona Matheson, Catriona Matheson Health Research Consultancy, Aberdeen, UK.

Oral papers 5: Pharmacists in general practice

An exploration of general practitioners’ and pharmacists’ views and experiences of integrating a pharmacist into general practice: a qualitative study

Ameerah Hasan Ibrahim, School of Pharmacy, Queen’s University Belfast, Belfast, UK.

Pharmacists in primary care in Scotland: a mixed-methods exploration of pharmacists’ perceptions of a national educational resource package

Kate Preston, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.

Development of a core set of clinical skills for pharmacist prescribers working in general practice: a Delphi study

Ameerah Hasan Ibrahim, School of Pharmacy, Queen’s University Belfast, Belfast, UK.

Oral papers 6: Prescribing trends and influences

Obesity association with antidiabetic drugs’ prescription among patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Fatema Mahmoud, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.

Prescribing differences among older adults with differing health cover and socioeconomic status: a cohort study

Ciaran Prendergast, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilisation of opioids in the English primary care setting: a segmented-linear regression analysis

Oula Sindi, Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UK.

Oral papers 7: Community pharmacy workforce development

Views and perceptions on the Designated Prescribing Practitioner role, barriers, and facilitators for its implementation in community pharmacy: a theory-based quantitative study

Tesnime Jebara, School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK.

Is the post-registration foundation programme fit for purpose for community pharmacists? An exploration of pharmacist experiences

Fiona McMillan, Pharmacy, NHS Education for Scotland, Glasgow, Scotland.

A survey of the community pharmacy workforce’s preparedness for, and response to, the COVID-19 pandemic in Northern Ireland

Susan Patterson, School of Pharmacy, Queen’s University Belfast, Belfast, UK.

Oral papers 8: Extended roles for pharmacists

With a new role comes new responsibilities: interviews to explore what Emergency Department Pharmacist Practitioners know and understand about patient safeguarding

Daniel Greenwood, School of Medicine, Anglia Ruskin University, Chelmsford, UK.

A qualitative evaluation of the attitudes, barriers, and facilitators relating to the provision of vaccine information by Irish community pharmacists

Kevin Murphy, School of Pharmacy, University College Cork, Cork, Ireland.

Assessing the impact on workflow of placing a pharmacy team in an emergency department

Antony Mitchell, Pharmacy Department, University Hospitals Plymouth, Plymouth, UK.

Oral papers 9: Adverse effects and safety

Safety of direct oral anticoagulants (DOACs) vs. warfarin for people aged ≥75 years with atrial fibrillation: a cohort study

Anneka Mitchell, Department of Pharmacy and Pharmacology, University of Bath, Bath, UK and Pharmacy Department, University Hospitals Plymouth, Plymouth, UK.

An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?

Tanja Mueller, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.

Potentially inappropriate prescribing in older adults with cancer receiving specialist palliative care: A retrospective analysis of medical records

Melanie Murphy, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Digital poster themes

  1. Health services response to Covid-19
  2. Language, communication and decision-making
  3. Pharmacy education and training
  4. Primary care
  5. Safe use of medicines
  6. Secondary and specialist care

Workshops

  1. Career paths for pharmacy professionals in academia and clinical academia
  2. Developing a consensus agenda on key priorities for pharmacy education research
  3. Successful approaches to engaging clinicians as stake holders and in implementation
  4. What works well in co-design of practice & health services research